K.J. Harrison & Partners Inc - CLARUS THERAPEUTICS HLDNGS I ownership

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 21 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
K.J. Harrison & Partners Inc ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$1,000
-50.0%
13,0000.0%0.00%
Q1 2022$2,000
-50.0%
13,0000.0%0.00%
-100.0%
Q4 2021$4,000
-60.0%
13,0000.0%0.00%0.0%
Q3 2021$10,00013,0000.00%
Other shareholders
CLARUS THERAPEUTICS HLDNGS I shareholders Q4 2021
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 91$00.00%
NOMURA HOLDINGS INC 85,000$00.00%
Context Capital Management, LLC 62,175$00.00%
MIZUHO SECURITIES USA LLC 100,000$1,0000.00%
Caption Management, LLC 140,821$00.00%
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders